In Person

16th World Clinical Biomarkers & Companion Diagnostics Summit

The summit where biopharma, diagnostic, and health leaders explore breakthroughs in multi-omics, digital pathology, and regulatory redefine how biomarkers power drug development and scalable personalized care.
5 – 8 Oct, 2026
Boston, MA
Sign up for updates
Healthcare experts discussing companion diagnostics and personalized healthcare solutions at a summit.

Key takeaways

  • Roche workshop “From Concept to Commercialization” was a big success with high engagement scores. Participants expressed enthusiasm to learn about Roche’s non-oncology pipeline with neurodegenerative biomarkers and alpha-synuclein.
  • The workshop also featured Roche’s computational pathology CDx solution describing how the acquisition of PathAI strengthens the digital pathology portfolio.
  • The Roche sponsored plenary session welcomed a patient sharing her story on ovarian cancer and how the FOLR1 test enabled her to get the right targeted treatment—bringing us all together and highlighting why precision medicine is so important.

Highlights

The 16th World Clinical Biomarkers & Companion Diagnostics Summit this year turned out to be the largest and most comprehensive forum to date. Convening 850+ senior leaders from biopharma, diagnostic, regulatory, healthcare, testing labs and multimodal communities, with expertise spanning the full value chain, attendees gained the insights, partnerships and insider know-how for continued advancement in the field of precision medicine.

Explore more

Register now for more information

Register now to stay informed on Roche’s latest activities.